XML 20 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Jan. 28, 2017
Jan. 30, 2016
Jan. 31, 2015
OPERATING ACTIVITIES:      
Net income $ 3,211 $ 2,689 $ 1,778
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation of fixed assets 8,139 5,191 4,388
Amortization of intangible assets 1,143    
Amortization of lease valuations, net (31) 23 136
Deferred tax benefit (6,988)    
Long term incentive compensation 1,306 538 487
Adjustment to contingent consideration (1,829)    
Loss on disposal of fixed assets 1,089 613 210
Gain on sale of property (1,164)    
Gain on sale of investments (800) (250)  
(Increase) decrease in cash surrender value (980) 356 (488)
Changes in operating assets and liabilities:      
Accounts receivable (1,755) (3) (861)
Merchandise inventory 8,650 6,331 23,790
Prepaid expenses and other (342) 4,666 415
Other assets 1,217 (2,561) 301
Accounts payable (4,469) (11,639) (14,098)
Accrued expenses, deferred revenue and other current liabilities (4,547) 707 (716)
Other long-term liabilities 2,586 1,302 1,466
Net cash provided by operating activities 4,436 7,963 16,808
INVESTING ACTIVITIES:      
Acquisition of a businesses (36,600)    
Purchases of fixed assets (24,672) (20,700) (8,774)
Proceeds from sale of assets 2,839 1,567  
Proceeds from sale of investments 1,600    
Purchases of investments (500) (1,052)  
Net cash used in investing activities (57,333) (20,185) (8,774)
FINANCING ACTIVITIES:      
Cash dividends paid     (16,036)
Exercise of long term equity awards 39 19 67
Payments of capital lease obligations   (938) (1,066)
Payments of long term borrowings (26,192)    
Proceeds from long term borrowings 21,463    
Purchase of treasury stock (2,647) (1,085) (3,464)
Net cash used in financing activities (7,337) (2,004) (20,499)
Net decrease in cash and cash equivalents (60,234) (14,226) (12,465)
Cash, cash equivalents, and restricted cash, beginning of year 104,311 118,537 131,002
Cash, cash equivalents, and restricted cash, end of year 44,077 104,311 118,537
Supplemental disclosures and non-cash investing and financing activities:      
Interest paid 775 1,861 1,953
Issuance of restricted performance based awards / deferred / restricted shares under deferred / restricted stock agreements 572 69 58
Cash, cash equivalents, and restricted cash, end of period 104,311 $ 104,311 $ 118,537
Less: restricted cash (16,103)    
Fair value of assets acquired, including cash acquired 93,152    
Liabilities assumed (24,256)    
Less: Fair value of shares issued as consideration (20,415)    
Less: Indemnity liability not yet paid (1,500)    
Acquisition of a business $ 36,600